Vivozon Pharmaceutical

KOSDAQ-082800
KOSDAQ
Electronic Components, not elsewhere classified
Global Rank
#18972
Country Rank
#599
Market Cap
239.02 M
Price
4.74
Change (%)
3.51%
Volume
201,421

Vivozon Pharmaceutical (KOSDAQ-082800) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
10/20/2023 1:5 x0.2 x0.2682651 Reverse
06/28/2013 1.041:1 x1.041 x1.341326 Forward
11/02/2009 1.049:1 x1.049 x1.288497 Forward
05/07/2009 1.13:1 x1.13 x1.22831 Forward
12/27/2006 1.087:1 x1.087 x1.087 Forward

Frequently Asked Questions

  • How much would Vivozon Pharmaceutical stock be worth if it never split?
    If Vivozon Pharmaceutical (stock symbol: KOSDAQ-082800) had never undergone any stock splits, its price per share today would be approximately 1.27 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-5) that occurred on 10/20/2023.
  • Vivozon Pharmaceutical (stock symbol: KOSDAQ-082800) has undergone a total of five stock splits. The most recent split occurred on 10/20/2023. One share bought prior to the first split on 12/27/2006 would now equal 0.27 shares.
  • Vivozon Pharmaceutical (stock symbol: KOSDAQ-082800) has undergone five stock splits in its history. The most recent split, a 1.087-for-1 split, occurred on 10/20/2023. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.